Whales with a lot of money to spend have taken a noticeably bullish stance on Amgen. Looking at options history for Amgen AMGN we detected 14 trades. If we consider the specifics of each trade, it ...

Amgen Inc.'s stock has surged 13% recently, likely due to promising developments with its obesity injection, MariTide, which offers unique benefits over current treatments. MariTide's dual ...

That’s the message from Fox News contributor Leslie Marshall after another unvaccinated person died from a measles outbreak in Texas and New Mexico. Marshall got into a back-and-forth with Mary ...

Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The company’s shares closed last Friday at $324.86.

Fox News pundit Leslie Marshall has faced backlash online after blasting President Trump's policies in a heated MediaBuzz segment - as viewers call for her to be taken off air. Contributors ...

Amgen and CytomX Therapeutics have kicked a phase 1 T-cell engager to the curb, axing the asset after assessing the clinical data and their pipeline priorities. CytomX signaled the EGFRxCD3 ...

Amgen (NASDAQ:AMGN) has announced the beginning of two Phase 3 studies for its weight loss candidate MariTide as the company aims to take a slice of a burgeoning obesity drug market dominated by ...

Amgen’s most advanced obesity asset MariTide is entering Maritime—that is, a phase 3 program that includes two freshly launched trials. Historically, the California-based pharma has remained ...

Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen ...

HYDERABAD: US-based biopharma giant on Monday opened its new technology and innovation centre in Hyderabad with its CEO Robert Bradway announcing a $200 million (approx Rs 1600 crore) investment ...